are compounded glp 1 still available Compounded-GLP-1 New project announcement: HHS‑OIG is

Managing weight loss with GLP-1 medications requires ongoing attention and timely tweaks

[00:04:05] Emily Field: No one starts a GLP one medication, excited to be on it for the rest of their life

For retailers and CPG manufacturers, the opportunity lies in developing products that deliver clear nutritional benefits without requiring shoppers to dramatically change their eating habits

[1] [5] While most GLP-1 medications are administered via subcutaneous injection (such as semaglutide, liraglutide, dulaglutide, or tirzepatide), with oral semaglutide (Rybelsus) as the only FDA-approved non-injectable option, transdermal patch delivery systems represent an emerging area of pharmaceutical development

Innovative studies have demonstrated the feasibility of biodegradable microneedle patches incorporating GLP-1 analogs such as exenatide and liraglutide, achieving sustained glucose-lowering effects in preclinical models

January 2026